Values First Advisors Inc. Sells 2,018 Shares of Evolent Health, Inc. (NYSE:EVH)

Values First Advisors Inc. lessened its holdings in Evolent Health, Inc. (NYSE:EVH) by 11.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,656 shares of the technology company’s stock after selling 2,018 shares during the period. Values First Advisors Inc.’s holdings in Evolent Health were worth $517,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of EVH. ICA Group Wealth Management LLC bought a new stake in shares of Evolent Health during the fourth quarter worth about $32,000. Captrust Financial Advisors grew its holdings in shares of Evolent Health by 254.4% during the second quarter. Captrust Financial Advisors now owns 1,758 shares of the technology company’s stock worth $54,000 after purchasing an additional 1,262 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in shares of Evolent Health by 75.6% in the third quarter. Tower Research Capital LLC TRC now owns 3,777 shares of the technology company’s stock worth $103,000 after acquiring an additional 1,626 shares during the period. West Tower Group LLC acquired a new position in shares of Evolent Health in the second quarter worth approximately $124,000. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Evolent Health by 389.3% in the third quarter. Nisa Investment Advisors LLC now owns 5,035 shares of the technology company’s stock worth $137,000 after acquiring an additional 4,006 shares during the period.

Evolent Health Stock Up 0.2 %

Shares of NYSE:EVH traded up $0.06 during trading on Thursday, reaching $32.79. 830,006 shares of the stock were exchanged, compared to its average volume of 989,808. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.01 and a quick ratio of 1.01. Evolent Health, Inc. has a 1-year low of $23.33 and a 1-year high of $36.70. The stock has a fifty day moving average of $31.82 and a two-hundred day moving average of $29.72. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of -25.78 and a beta of 1.54.

Evolent Health (NYSE:EVH) last issued its earnings results on Thursday, February 22nd. The technology company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.13. Evolent Health had a positive return on equity of 6.60% and a negative net margin of 5.76%. The company had revenue of $556.06 million for the quarter, compared to analyst estimates of $541.87 million. Research analysts anticipate that Evolent Health, Inc. will post 0.87 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on EVH. Canaccord Genuity Group cut their price objective on Evolent Health from $45.00 to $44.00 and set a “buy” rating on the stock in a research note on Thursday. Oppenheimer began coverage on Evolent Health in a research note on Friday, March 1st. They issued an “outperform” rating and a $45.00 price objective on the stock. JMP Securities lifted their price objective on Evolent Health from $37.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Friday, February 23rd. JPMorgan Chase & Co. dropped their price target on Evolent Health from $53.00 to $52.00 and set an “overweight” rating on the stock in a research note on Friday, March 15th. Finally, Barclays started coverage on Evolent Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $39.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $42.70.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.